Skip to main content
Show full summary

Lord Hunt of Kings Heath to ask His Majesty's Government what assessment they have made of international phase 3 clinical trials which suggest that Vorasidenib could offer a new treatment option for low-grade glioma; and whether they intend to make it available to brain tumour patients.  HL3063

Question HL3063: tabled on 6 March 2024 and due for answer by 20 March 2024

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Hunt of Kings Heath to ask His Majesty's Government what assessment they have made of international phase 3 clinical trials which suggest that Vorasidenib could offer a new treatment option for low-grade glioma; and whether they intend to make it available to brain tumour patients.  HL3063
Legend for business item text
Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.